Xiaobin Wu
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 10%
- RNA modifications and cancer
- Cancer-related gene regulation
- Epigenetics and DNA Methylation
- RNA Research and Splicing
- Circular RNAs in diseases
Papers in
-
- RNA modifications and cancer 5
- Single-cell and spatial transcriptomics 4
- Photosynthetic Processes and Mechanisms 3
- Circular RNAs in diseases 3
- Extracellular vesicles in disease 3
-
- Cancer-related molecular mechanisms research 6
- MicroRNA in disease regulation 3
- Co-authors
- Honglei Chen (2 shared papers)Yi Niu (1 shared paper)Lei Sun (1 shared paper)Bo Wei (1 shared paper)Ziyou Lin (1 shared paper)Arabella Wan (1 shared paper)Heng Liang (1 shared paper)Guohui Wan (1 shared paper)
In The Last Decade
Xiaobin Wu
29 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 101
- Cancer Research 392
- Molecular Biology 806
- Signal Processing 34
- Oncology 83
- Biotechnology 26
Countries citing papers authored by Xiaobin Wu
This map shows the geographic impact of Xiaobin Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaobin Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaobin Wu more than expected).
Fields of papers citing papers by Xiaobin Wu
This network shows the impact of papers produced by Xiaobin Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaobin Wu. The network helps show where Xiaobin Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaobin Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3 Hit paper breakdown → | 2019 | 455 |
| 2 | 2019 | 90 | |
| 3 | 2015 | 86 | |
| 4 | 2018 | 68 | |
| 5 | 2004 | 54 | |
| 6 | 2018 | 37 | |
| 7 | 2021 | 33 | |
| 8 | 2013 | 30 | |
| 9 | 2022 | 24 | |
| 10 | 2010 | 23 | |
| 11 | 2022 | 22 | |
| 12 | 2015 | 21 | |
| 13 | 2019 | 17 | |
| 14 | 2018 | 15 | |
| 15 | 2003 | 15 | |
| 16 | 2019 | 13 | |
| 17 | 2013 | 8 | |
| 18 | 2023 | 7 | |
| 19 | 2010 | 7 | |
| 20 | 2021 | 6 |
About Xiaobin Wu
Xiaobin Wu is a scholar working on Molecular Biology, Cancer Research, Artificial Intelligence, Pathology and Forensic Medicine and Information Systems, having authored 31 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (6 papers), RNA modifications and cancer (5 papers), Single-cell and spatial transcriptomics (4 papers), MicroRNA in disease regulation (3 papers), Text and Document Classification Technologies (3 papers), Photosynthetic Processes and Mechanisms (3 papers), Circular RNAs in diseases (3 papers) and Extracellular vesicles in disease (3 papers). The work is most often cited by research in Cancer Research (392 citations), Molecular Biology (806 citations), Signal Processing (34 citations), Oncology (83 citations) and Biotechnology (26 citations). Xiaobin Wu has collaborated with scholars based in China, Canada and Hong Kong. Frequent co-authors include Honglei Chen, Yi Niu, Lei Sun, Bo Wei, Ziyou Lin, Arabella Wan, Heng Liang, Guohui Wan, Yuan Wang and Xi Li. Their work appears in journals such as Frontiers in Cell and Developmental Biology, International Journal of Molecular Sciences, Biochemical and Biophysical Research Communications, IEEE Journal on Selected Areas in Communications and Biotechnology Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.